Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. From Wikipedia
Phase-3 results demonstrated a 20% higher cure rate over meropenem with forecasts valuing the drug at $9 billion globally
